Cushion partners with Psychemedics Corporation to provide a superior detection of drug abuse using their patented hair analysis method. Psychemedics is the world’s first laboratory to offer a cost-effective method for testing hair rather than body fluids for the detection of drugs of abuse. The company was also the first hair testing company to receive clearance from the Food and Drug Administration and the College of American Pathologists.
Psychemedics holds the first U.S. and foreign patents ever issued to detect the presence of drugs in hair. This patented technology is a proven drug testing process that not only can detect if drugs of abuse have been used, but can also provide information on the quantity and historic pattern of individual drug use in most instances. The company uses its patented technology to liquefy the hair, releasing essentially 100% of the drugs present.
Psychemedics has a legal track record which reflects their superior technology and dedication to supporting the results. The test results have been continuously upheld by state and federal courts and in administrative agency hearings and arbitrations. Psychemedics performs more hair tests than all other labs combined. Psychemedics is a publicly-held corporation listed on NASDAQ under the ticker symbol PMD.